Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021 Biotech Investing
BLINCYTO® Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Biotech Investing
Terra Nova Resources Inc. Announces Conditional Approval of Fundamental Change and Announces Effective Date for Name Change and Share Consolidation Biotech Investing
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options Biotech Investing
Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference Biotech Investing
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma Biotech Investing
